|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn568043994 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
080716s2008 dcua ob 000 0 eng d |
040 |
|
|
|a CCO
|b eng
|e pn
|c CCO
|d E7B
|d OCLCQ
|d MMU
|d COD
|d MEAUC
|d IDEBK
|d OCLCQ
|d ORU
|d OCLCQ
|d OCLCF
|d OCLCQ
|d NLGGC
|d YDXCP
|d OCLCQ
|d N$T
|d OCLCQ
|d EBLCP
|d DEBSZ
|d AZK
|d YDX
|d PIFAG
|d ZCU
|d CASUM
|d OCLCQ
|d MERUC
|d OCLCO
|d MERER
|d OCLCQ
|d U3W
|d BUF
|d OCLCO
|d CUY
|d OCLCQ
|d STF
|d WRM
|d COCUF
|d UAB
|d NRAMU
|d EZ9
|d ICG
|d OCLCO
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCA
|d LVT
|d OCLCA
|d DKC
|d OCLCO
|d OCLCQ
|d UKAHL
|d OCLCQ
|d OCLCA
|d UKCRE
|d SDF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
019 |
|
|
|a 228159185
|a 503447125
|a 646755981
|a 666938404
|a 815688524
|a 923278309
|a 961539501
|a 962592791
|a 991959483
|a 999655337
|a 1037925733
|a 1038694359
|a 1045484306
|a 1047537829
|a 1055338406
|a 1064724992
|a 1081248420
|a 1153480511
|a 1156333915
|a 1228565180
|a 1249253468
|
020 |
|
|
|a 9780309114318
|q (electronic bk.)
|
020 |
|
|
|a 0309114314
|q (electronic bk.)
|
020 |
|
|
|z 1281767476
|
020 |
|
|
|z 9781281767479
|
020 |
|
|
|z 0309114306
|
020 |
|
|
|z 9780309114301
|
029 |
1 |
|
|a AU@
|b 000051504025
|
029 |
1 |
|
|a AU@
|b 000068366150
|
029 |
1 |
|
|a DEBBG
|b BV044108822
|
029 |
1 |
|
|a DEBSZ
|b 452575621
|
029 |
1 |
|
|a NZ1
|b 13335977
|
035 |
|
|
|a (OCoLC)568043994
|z (OCoLC)228159185
|z (OCoLC)503447125
|z (OCoLC)646755981
|z (OCoLC)666938404
|z (OCoLC)815688524
|z (OCoLC)923278309
|z (OCoLC)961539501
|z (OCoLC)962592791
|z (OCoLC)991959483
|z (OCoLC)999655337
|z (OCoLC)1037925733
|z (OCoLC)1038694359
|z (OCoLC)1045484306
|z (OCoLC)1047537829
|z (OCoLC)1055338406
|z (OCoLC)1064724992
|z (OCoLC)1081248420
|z (OCoLC)1153480511
|z (OCoLC)1156333915
|z (OCoLC)1228565180
|z (OCoLC)1249253468
|
050 |
|
4 |
|a RA643.83
|b .M48 2008eb
|
060 |
|
4 |
|a 2008 I-120
|
060 |
|
4 |
|a WC 503.6
|b M592 2008
|
072 |
|
7 |
|a MBN
|2 bicssc
|
072 |
|
7 |
|a POL
|x 027000
|2 bisacsh
|
072 |
|
7 |
|a POL
|x 019000
|2 bisacsh
|
082 |
0 |
4 |
|a 362.196/9792
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Methodological challenges in biomedical HIV prevention trials /
|c Committee on the Methodological Challenges in HIV Prevention Trials, Board on Global Health, Institute of Medicine of the National Academies ; Stephen W. Lagakos and Alicia R. Gable, editors.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c ©2008.
|
300 |
|
|
|a 1 online resource (xi, 258 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
520 |
|
|
|a "This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials."
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Matter -- Reviewers -- Contents -- Summary -- Introduction -- 1 The Status and Challenges of Biomedical HIV Prevention Trials -- 2 Basic Design Features: Size, Duration, and Type of Trials, and Choice of Control Group -- 3 Design Considerations: Risk-Reduction Counseling -- 4 Design Considerations: Pregnancy -- 5 Design Considerations: Adherence -- 6 Design Considerations: Recruitment and Retention -- 7 Site Preparedness -- 8 Estimating HIV Incidence -- 9 Interim Monitoring and Analysis of Results -- 10 Alternative Designs -- Appendixes
|
505 |
8 |
|
|a Appendix A: Public Committee Meeting AgendasAppendix B: Acronyms -- Appendix C: Supporting Materials for Chapter 2 -- Appendix D: Methods for Analyzing Adherence -- Appendix E: Committee Biographies
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a AIDS (Disease)
|x Prevention.
|
650 |
1 |
2 |
|a HIV Infections
|x prevention & control
|
650 |
1 |
2 |
|a Clinical Trials as Topic
|
650 |
2 |
2 |
|a Program Evaluation
|x methods
|
650 |
2 |
2 |
|a Anti-Infective Agents
|x therapeutic use
|
650 |
2 |
2 |
|a Anti-Retroviral Agents
|x therapeutic use
|
650 |
|
6 |
|a Sida
|x Prévention.
|
650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Security.
|2 bisacsh
|
650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Services & Welfare.
|2 bisacsh
|
650 |
|
7 |
|a AIDS (Disease)
|x Prevention
|2 fast
|
700 |
1 |
|
|a Gable, Alicia.
|
700 |
1 |
|
|a Lagakos, Stephen W.
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee on the Methodological Challenges in HIV Prevention Trials.
|
758 |
|
|
|i has work:
|a Methodological challenges in biomedical HIV prevention trials (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFVtMyqqMCwjJr9VFmqQpX
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Methodological challenges in biomedical HIV prevention trials.
|d Washington, D.C. : National Academies Press, ©2008
|z 9780309114301
|w (DLC) 2008299718
|w (OCoLC)223867780
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378378
|z Texto completo
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36616625
|
938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH36558066
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3378378
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 233557
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 6011478
|
994 |
|
|
|a 92
|b IZTAP
|